Via TNF-α/nuclear factor kappa B (NF-κB) and phosphatidylinositol 3-kinase (PI3K)/AKT pathways, sotetsuflavone suppresses the migration and invasion of NSCLC cells and may be effective in treating the tumor [35]. Here, AKT1 is linked to neoplasm.